ELMD

Electromed, Inc.

$27.18

0.44%
SectorHealthcareIndustryMedical DevicesCountryUnited States

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company provides SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.

Source: Yahoo Finance
AI summary

Price & performance

1M-4.4%
3M-30.9%
YTD-3.7%
1Y+6.8%
52-week range—
Beta0.72
Full chart and returns against a benchmark

Q-Score

92/ 100

Quality against peers; 50 is the peer median.

Growth74
Risk68
Performance68
Valuation66
Profitability90
Leverage87
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2026

Revenue$73.8M+15.3%
Net income$11.3M+49.9%
Net margin15.3%+3.5 pts
Historical fundamentals

Revenue exposure

0%of revenue from outside the US
United States100%
Regions, segments, customers and suppliers

Valuation

ELMDIndustryP/E19.9329.61P/S3.053.49EV/EBITDA13.8918.38P/B4.173.39PEG0.400.40
Dividend yield0.00%
Every valuation metric

Earnings

Nov 10next report, after the close
EPS estimate—
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate